Literature DB >> 23128459

The prevalence of health care-associated infections and risk factors in a university hospital.

Greta Gailienė1, Zita Gierasimovič, Daiva Petruševičienė, Aušra Macijauskienė.   

Abstract

UNLABELLED: The aim of the study was to evaluate the prevalence of health care-associated infections, risk factors, and antimicrobial use.
MATERIAL AND METHODS: The study was carried out as a point-prevalence study in acute care wards, i.e., intensive care, surgical, and medical wards, at Vilnius University Hospital Santariškių Klinikos in April 2010. The study variables included the patient's general data, indwelling devices, surgery, infection and its microbiological investigation, and antimicrobial use. All the variables that were logically related or had a P value of <0.25 in the univariate analysis were included in the stepwise logistic regression in order to study the factors potentially associated with health care-associated infections.
RESULTS: A total of 731 patients were surveyed. The overall prevalence rate of health care-associated infections was 3.8%. The prevalence of health care-associated infections differed by hospital wards (range 0.0%-19.2%). The lower respiratory tract (32.2%), urinary tract (28.5%), and surgical site infections (32.1%) were the most common health care-associated infections. Moreover, 89.3% of the cases of health care-associated infections were microbiologically investigated. Staphylococcus aureus (28.6%) and Escherichia coli (19.1%) were the most frequently isolated microorganisms. The use of one or more invasive devices was recorded in 332 patients (45.4%). Of the surveyed patients, 20.2% received antimicrobial agents. The most commonly prescribed antimicrobial agents were fluoroquinolones (21.1%), broad-spectrum penicillins (19.1%), and first- or second-generation cephalosporins (18.6%).
CONCLUSIONS: The prevalence of health care-associated infections was found to be similar to the reported overall prevalence rate of health care-associated infections in acute care hospitals in Lithuania.

Entities:  

Mesh:

Year:  2012        PMID: 23128459

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  6 in total

1.  Perceived Barriers and Preventive Measures of COVID-19 Among Healthcare Providers in Debretabor, North Central Ethiopia, 2020.

Authors:  Binyam Minuye Birihane; Wubet Alebachew Bayih; Abebaw Yeshambel Alemu; Demeke Mesfin Belay
Journal:  Risk Manag Healthc Policy       Date:  2020-11-20

2.  Risk factors for hospital-acquired infections in teaching hospitals of Amhara regional state, Ethiopia: A matched-case control study.

Authors:  Walelegn Worku Yallew; Abera Kumie; Feleke Moges Yehuala
Journal:  PLoS One       Date:  2017-07-18       Impact factor: 3.240

3.  Bacterial profile and their antimicrobial susceptibility patterns in patients admitted at MaddaWalabu University Goba Referral Hospital, Ethiopia: a cross sectional study.

Authors:  Meseret Mitiku Gemechu; Tesfaye Assefa Tadesse; Getahun Negash Takele; Fithamlak Solomon Bisetegn; Yonas Alem Gesese; Tizazu Zenebe Zelelie
Journal:  Afr Health Sci       Date:  2021-06       Impact factor: 0.927

4.  Antimicrobial resistance profiles and associated factors of Acinetobacter and Pseudomonas aeruginosa nosocomial infection among patients admitted at Dessie comprehensive specialized Hospital, North-East Ethiopia. A cross-sectional study.

Authors:  Habtamu Mekonnen; Abdurahaman Seid; Genet Molla Fenta; Teklay Gebrecherkos
Journal:  PLoS One       Date:  2021-11-15       Impact factor: 3.240

5.  Risk Factors for Inappropriate Antimicrobial Therapy Among Patients with Hospital-Acquired Infection at Jimma Medical Center: A Prospective Observational Study.

Authors:  Genene Adane Debela; Behailu Terefe Tesfaye; Mengist Awoke Yizengaw
Journal:  Infect Drug Resist       Date:  2022-03-04       Impact factor: 4.003

6.  Management of hospital-acquired infections among patients hospitalized at Zewditu memorial hospital, Addis Ababa, Ethiopia: A prospective cross-sectional study.

Authors:  Segen Gebremeskel Tassew; Minyahil Alebachew Woldu; Wondwossen Amogne Degu; Workineh Shibeshi
Journal:  PLoS One       Date:  2020-04-24       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.